- Merck
- For the prevention of diseases caused by Clostridium chauvoei, C. septicum, C. novyi Type B, C. haemolyticum (known also as C. novyi Type D), C. tetani and C. perfringens Types C and D
- For Sheep & Cattle
- 10 Dose
- 007-472930
Immunity is also provided as an aid in the prevention of diseases caused by the beta and epsilon toxins of an additional organism, C. perfringens Type B. Although C. perfringens Type B is not a significant problem in North America (US), immunity is derived from a combination of Type C (beta) and Type D (epsilon) C. perfringens fractions.
SHEEP: 5 mL injection administered subcutaneously followed by a second 2 mL dose given six weeks later. Revaccinate annually with 2 mL prior to periods of extreme risk or parturition.
PRECAUTION: This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions. Local reactions may be observed following subcutaneous administration to cattle.
CAUTION: Store at 35°-45°F (2°-7°C). Protect from freezing. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.